[0JBU] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[0JBU] Intellia Therapeutics, Inc.
Announcement Date
22-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -1.48%
Quarter Report
0JBU's Result
0JBU's Financial Summary
View:
Show?
Annual Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 57,877 36,275 52,121 33,053 57,994 43,103 30,434 11.29%
PBT -519,021 -481,192 -474,186 -267,892 -134,231 -99,533 -85,343 35.06%
Tax 0 0 16,022 -8,174 0 -6,835 0 -
NP -519,021 -481,192 -474,186 -267,892 -134,231 -99,533 -85,343 35.06%
Tax Rate - - - - - - - -
Total Cost 576,898 517,467 526,307 300,945 192,225 142,636 115,777 30.65%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -896.77 -1,326.51 -909.78 -810.49 -231.46 -230.92 -280.42 21.35%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -5.25 -5.42 -6.16 -3.78 -2.40 -1.96 -1.98 17.62%
EPS Diluted -5.25 -5.42 -6.16 -3.78 -2.40 -1.96 -1.98 17.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.